Felice Verduyn-Van Weegen

Felice Verduyn-van Weegen joined LSP early in 2015. In addition to Evommune Inc., Felice serves on the Boards of a.o. VICO Therapeutics, Amolyt Pharma and AM-Pharma. Prior to joining LSP, Felice was a consultant at McKinsey & Company with a primary focus on healthcare projects. Before McKinsey, she was a neuroscientist and statistical geneticist, working with the prestigious complex traits genetics group at the Broad Institute and Harvard Medical School. Felice was awarded a bachelor’s degree in Biological Psychology and a master’s degree in Neuroscience from the VU University, Amsterdam. In addition, she has an MBA from Columbia Business School.